Lecanemab in Early Alzheimer’s Disease
Lecanemab reduced markers of amyloid in early Alzheimer's disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months but was...
Publications
View AllRegional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease
Significance Beta-amyloid plaque accumulation, glucose hypometabolism, and neuronal atrophy are hallmarks of Alzheimer’s disease. However, the regional ordering of these biomark...
Affiliated Researchers
Institution Info
- Type
- nonprofit
- Country
- US
- Publications
- 2
- Citations
- 4,658
External Links
Identifiers
- ROR
- https://ror.org/01j20wc74